Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Zika Virus has Oncolytic Activity Against Glioblastoma Stem Cells.

Literature DB >> 29669124

Zika Virus has Oncolytic Activity Against Glioblastoma Stem Cells.

Jonathan A Lubin¹, Ray R Zhang¹, John S Kuo¹.

Abstract

Entities: Disease Species

Year: 2018 PMID： 29669124 PMCID： PMC6257021 DOI： 10.1093/neuros/nyy047

Source DB: PubMed Journal: Neurosurgery ISSN： 0148-396X Impact factor: 4.654

× No keyword cloud information.

4 in total

Review 1. Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients.

Authors: Pedro R Lowenstein; Maria G Castro
Journal: Clin Immunol Date: 2017-07-15 Impact factor: 3.969

2. Experimental therapy of human glioma by means of a genetically engineered virus mutant.

Authors: R L Martuza; A Malick; J M Markert; K L Ruffner; D M Coen
Journal: Science Date: 1991-05-10 Impact factor: 47.728

3. Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma.

Authors: Timothy F Cloughesy; Joseph Landolfi; Daniel J Hogan; Stephen Bloomfield; Bob Carter; Clark C Chen; J Bradley Elder; Steven N Kalkanis; Santosh Kesari; Albert Lai; Ian Y Lee; Linda M Liau; Tom Mikkelsen; Phioanh Leia Nghiemphu; David Piccioni; Tobias Walbert; Alice Chu; Asha Das; Oscar R Diago; Dawn Gammon; Harry E Gruber; Michelle Hanna; Douglas J Jolly; Noriyuki Kasahara; David McCarthy; Leah Mitchell; Derek Ostertag; Joan M Robbins; Maria Rodriguez-Aguirre; Michael A Vogelbaum
Journal: Sci Transl Med Date: 2016-06-01 Impact factor: 17.956

4. Zika virus has oncolytic activity against glioblastoma stem cells.

Authors: Zhe Zhu; Matthew J Gorman; Lisa D McKenzie; Jiani N Chai; Christopher G Hubert; Briana C Prager; Estefania Fernandez; Justin M Richner; Rong Zhang; Chao Shan; Eric Tycksen; Xiuxing Wang; Pei-Yong Shi; Michael S Diamond; Jeremy N Rich; Milan G Chheda
Journal: J Exp Med Date: 2017-09-05 Impact factor: 14.307

4 in total

11 in total

1. The Propagation and Quantification of Two Emerging Oncolytic Viruses: Vesicular Stomatitis (VSV) and Zika (ZIKV).

Authors: Robert E Means; Sounak Ghosh Roy; Samuel G Katz
Journal: Methods Mol Biol Date: 2020

2. Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma.

Authors: Hans-Georg Wirsching; Huajia Zhang; Frank Szulzewsky; Sonali Arora; Paola Grandi; Patrick J Cimino; Nduka Amankulor; Jean S Campbell; Lisa McFerrin; Siobhan S Pattwell; Chibawanye Ene; Alexandra Hicks; Michael Ball; James Yan; Jenny Zhang; Debrah Kumasaka; Robert H Pierce; Michael Weller; Mitchell Finer; Christophe Quéva; Joseph C Glorioso; A McGarry Houghton; Eric C Holland
Journal: JCI Insight Date: 2019-07-11

Review 3. Glioblastoma Treatment Modalities besides Surgery.

Authors: Hao Zhang; Ruizhe Wang; Yuanqiang Yu; Jinfang Liu; Tianmeng Luo; Fan Fan
Journal: J Cancer Date: 2019-08-27 Impact factor: 4.207

4. Novel modulators of p53-signaling encoded by unknown genes of emerging viruses.

Authors: Dina Alzhanova; Kathleen Corcoran; Aubrey G Bailey; Kristin Long; Sharon Taft-Benz; Rachel L Graham; Grant S Broussard; Mark Heise; Gabriele Neumann; Peter Halfmann; Yoshihiro Kawaoka; Ralph S Baric; Blossom Damania; Dirk P Dittmer
Journal: PLoS Pathog Date: 2021-01-07 Impact factor: 6.823

5. Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade.

Authors: Sharmila Nair; Luciano Mazzoccoli; Arijita Jash; Jennifer Govero; Sachendra S Bais; Tong Hu; Camila R Fontes-Garfias; Chao Shan; Hideho Okada; Sujan Shresta; Jeremy N Rich; Pei-Yong Shi; Michael S Diamond; Milan G Chheda
Journal: JCI Insight Date: 2021-01-11

Zika Virus has Oncolytic Activity Against Glioblastoma Stem Cells.

Review 1. Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients.

2. Experimental therapy of human glioma by means of a genetically engineered virus mutant.

3. Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma.

4. Zika virus has oncolytic activity against glioblastoma stem cells.

1. The Propagation and Quantification of Two Emerging Oncolytic Viruses: Vesicular Stomatitis (VSV) and Zika (ZIKV).

2. Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma.

Review 3. Glioblastoma Treatment Modalities besides Surgery.

4. Novel modulators of p53-signaling encoded by unknown genes of emerging viruses.

5. Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade.

Review 6. Zika Virus: A New Therapeutic Candidate for Glioblastoma Treatment.

Review 7. Zika Virus Neuropathogenesis: The Different Brain Cells, Host Factors and Mechanisms Involved.

8. AXL receptor is required for Zika virus strain MR-766 infection in human glioblastoma cell lines.

9. Zika Virus with Increased CpG Dinucleotide Frequencies Shows Oncolytic Activity in Glioblastoma Stem Cells.

Review 10. Oncolytic Viruses as a Platform for the Treatment of Malignant Brain Tumors.